Note: Igm Biosciences's revenues are gauged from an analysis of company filings.
Igm Biosciences's Income Statement (based on Industry Averages)
Igm Biosciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Igm Biosciences is developing and marketing.
Igm Biosciences doesn't have any recent trademark applications, indicating Igm Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
IGM BIOSCIENCES Research and development services in the field of antibodies; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical research and scientific research information in the field of oncology; biotechnology research; research and development in the pharmaceutical and biotechnology fields
05/01/2019
See all trademarks and details in the Full Report.
Market Share of Igm Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Igm Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Igm Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Igm Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.